The adoption of digital medicines, also known as digital therapies, has been challenging prior to the pandemic. Clinical validation and FDA approvals have gradually moved the needle on how these treatments are perceived. But the need for remote patient monitoring for chronic conditions during the Covid-19 pandemic has led to increased interest in this area in hopes that it will continue to rise beyond the pandemic.
Many of the available digital medicines focus on behavioral health needs. The social isolation associated with the Covid-19 pandemic exacerbated or led to stress, depression, anxiety and substance abuse.
The future of digital medicine is just one of the panel discussions offered on MedCity INVESTING PharmaTecha virtual conference scheduled for July 26. It will bring together technology disruptors, Big Pharma and biotech leaders, investors and entrepreneurs to discuss how to adopt digital strategies to transform every aspect of the pharmaceutical industry.
To sign up for free, click here†
The digital medicine landscape is promising. A new generation of companies wants to transform the digital therapy market. Learn from pharma, digital health and commercialization experts.
Among the speakers on the panel are:
The panel discussions will conclude with a startup pitch competition. The theme of this mini Pitch Perfect is reinventing clinical trials† The application deadline is May 31. To apply, click here†
Follow this link to register as a speaker at INVEST PharmaTech. The deadline to apply is May 26.
For information to sponsor the conference, from a panel discussion to a video spotlight, email: [email protected]
Photo: Who_I_am, Getty Images